Table 3.
Follow-up Results, HASBLED Score, and TTR Results
CHA2DS2-VASc Score Risk Classification | Low-Medium Risk (n = 349) | High Risk (n = 2243) | P | Total (n = 2592) |
---|---|---|---|---|
Follow-up time (day) | 2072 (1197-2188) | 1626 (880-2130) | <.001 | 1920 (939-2133) |
Ischemic CVD/TIA in follow-up, n (%) | 6 (1.7) | 136 (6.1) | .001 | 14(5.5) |
Hemorrhagic CVD in follow-up, n (%) | 1 (0.3) | 11 (0.5) | .505 | 12 (0.5) |
Death at first-year follow-up, n (%) | 6 (1.7) | 231 (10.3) | <.001 | 237 (9.1) |
Death at fifth-year follow-up, n (%) | 36 (10.3) | 725 (32.3) | <.001 | 761 (29.4) |
HASBLED score | 0 (0-1) | 2 (1-2) | <.001 | 1 (1-2) |
TTR (%) | 49.0 (26-85.4) | 40 (22.8-70) | .163 | 40 (23-70) |
P value of <.05 shows statistical significance.
CVD, cerebrovascular disease; TIA, transient ischemic attack; TTR, time in therapeutic range.